8 research outputs found

    Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27

    Get PDF
    Background: Despite its effectiveness in the treatment of various cancers, the use of doxorubicin is limited by a potentially fatal cardiomyopathy. Prevention of this cardiotoxicity remains a critical issue in clinical oncology. We hypothesized that flavaglines, a family of natural compounds that display potent neuroprotective effects, may also alleviate doxorubicininduced cardiotoxicity. Methodology/Principal Findings: Our in vitro data established that a pretreatment with flavaglines significantly increased viability of doxorubicin-injured H9c2 cardiomyocytes as demonstrated by annexin V, TUNEL and active caspase-3 assays. We demonstrated also that phosphorylation of the small heat shock protein Hsp27 is involved in the mechanism by which flavaglines display their cardioprotective effect. Furthermore, knocking-down Hsp27 in H9c2 cardiomyocytes completely reversed this cardioprotection. Administration of our lead compound (FL3) to mice attenuated cardiomyocyte apoptosis and cardiac fibrosis, as reflected by a 50 % decrease of mortality. Conclusions/Significance: These results suggest a prophylactic potential of flavaglines to prevent doxorubicin-induce

    SynthÚse d'analogues de produits naturels anticancéreux, cardioprotecteurs et neuroprotecteurs (les flavaglines)

    No full text
    Les flavaglines sont des molĂ©cules naturelles, extraites de plantes, qui prĂ©sentent un rĂ©el potentiel anticancĂ©reux, mais Ă©galement des propriĂ©tĂ©s cardioprotectrices vis-Ă -vis de la cardiotoxicitĂ© induite par les anthracyclines et des propriĂ©tĂ©s neuroprotectrices.L objectifs principal de cette thĂšse a Ă©tĂ© de synthĂ©tiser des analogues des flavaglines afin d Ă©tudier les relations structure-activitĂ© pour ces diffĂ©rentes activitĂ©s. Trente-six analogues diversement substituĂ©s en cinq positions ont Ă©tĂ© obtenus, ce qui a permis de montrer que si les requis structuraux sont globalement similaires pour ces trois activitĂ©s, des diffĂ©rences subtiles ont ĂȘtre mises en Ă©vidence. Nous avons notamment pu mettre en Ă©vidence que l introduction de substituants en position 2 a un effet dĂ©lĂ©tĂšre pour l activitĂ© anticancĂ©reuse sur les cellules multirĂ©sistantes. En revanche, le remplacement de l alcool par un formamide en position 1, avec inversion de configuration, augmente l activitĂ© cytotoxique et donne accĂšs Ă  un composĂ© qui permet de rĂ©duire l accroissement de tumeurs dans un modĂšle murin.Une flavagline conjuguĂ©e Ă  une dimĂ©thylaminocoumarine a Ă©galement Ă©tĂ© synthĂ©tisĂ©e. Cette sonde de fluorescence a permis de montrer que les flavaglines se fixent sur leur cible molĂ©culaire au niveau du rĂ©ticulum endoplasmique. Nous avons Ă©galement prĂ©parĂ© un ligand de chromatographie qui a permis d isoler ces cibles molĂ©culaires.Finalement, la potentialisation des effets anticancĂ©reux d autres mĂ©dicaments et leurs facultĂ©s Ă  diminuer les effets secondaires au niveau cardiaque et neuronal confĂšrent aux flavaglines un rĂ©el potentiel thĂ©rapeutique.The flavaglines are natural compounds, extracted from plants, which possess unique anticancer properties, display potent neuroprotective effects and may protect cardiomyocytes from cardiotoxicity induce by anthracyclines.The objective of this work was the synthesis of analogues and the study of the relation structure-activity (RSA). The variations on five different positions gave us important insight on the nature of substituent for activity. In general, the RSA on the anticancer properties, neuro- and cardioprotection were globally the same, with subtle differences. Importantly, the introduction of substituents at C-2 was deleterious on multidrug resistance cancer cell lines; and the replacement of the hydroxyl group at C-1 by an aminoformyl with the opposite configuration enhances the cytotoxicity. This work has led to an analogue that reduces tumors growth in an allograft model at non-toxic doses.Two tools to identify the biological target of flavaglines were synthesized. The first is a flavagline derivative conjugated to a dimethylaminocoumarin that allowed visualizing the accumulation of flavagline in the reticulum endoplasmic. The second is an affinity ligand for pull-down experiment and which permit to isolate the target of flavaglines.Finally, this work demonstrated that flavaglines have a real therapeutic effect for the treatment of cancer and their iatrogen effects.STRASBOURG-Sc. et Techniques (674822102) / SudocSudocFranceF
    corecore